With the coronavirus outbreak disrupting supply of active pharmaceutical ingredients (APIs) and medical devices from China to India, the government has come out with four schemes worth Rs 13,760 crore to encourage manufacturing of bulk drugs and medical devices in the country and their exports. On March 21, the…
The industry associations — Indian Drug Manufacturers’ Association (IDMA), Organisation of Pharmaceutical Producers of India (OPPI), Pharmaceuticals Export Promotion Council of India (Pharmexcil), among others have given an undertaking that all restricted molecules for export are sufficiently available for next four months. The undertaking was given by industry bodies…
Ipca Laboratories, for instance, was supposed to deliver 5 lakh blisters of hydroxychloroquine (HCQS) tablets to the Central government by last Tuesday, but it had delivered the tablets after two days by air due to delay in permission from the government to airlift the product from its Siliguri facility.Though…
Donec ornare ornare lacinia. Praesent ullamcorper pretium elit in sodales. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nam nec lorem nec nibh volutpat pellentesque. Nunc porttitor quam eget blandit tempor. Fusce in est lacus. Aliquam commodo ultricies diam vel consequat. Aenean faucibus diam…
Donec ornare ornare lacinia. Praesent ullamcorper pretium elit in sodales. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nam nec lorem nec nibh volutpat pellentesque. Nunc porttitor quam eget blandit tempor. Fusce in est lacus. Aliquam commodo ultricies diam vel consequat. Aenean faucibus diam…
Donec ornare ornare lacinia. Praesent ullamcorper pretium elit in sodales. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nam nec lorem nec nibh volutpat pellentesque. Nunc porttitor quam eget blandit tempor. Fusce in est lacus. Aliquam commodo ultricies diam vel consequat. Aenean faucibus diam…
Donec ornare ornare lacinia. Praesent ullamcorper pretium elit in sodales. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nam nec lorem nec nibh volutpat pellentesque. Nunc porttitor quam eget blandit tempor. Fusce in est lacus. Aliquam commodo ultricies diam vel consequat. Aenean faucibus diam…
Donec ornare ornare lacinia. Praesent ullamcorper pretium elit in sodales. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nam nec lorem nec nibh volutpat pellentesque. Nunc porttitor quam eget blandit tempor. Fusce in est lacus. Aliquam commodo ultricies diam vel consequat. Aenean faucibus diam…
Donec ornare ornare lacinia. Praesent ullamcorper pretium elit in sodales. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nam nec lorem nec nibh volutpat pellentesque. Nunc porttitor quam eget blandit tempor. Fusce in est lacus. Aliquam commodo ultricies diam vel consequat. Aenean faucibus diam…
Donec ornare ornare lacinia. Praesent ullamcorper pretium elit in sodales. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nam nec lorem nec nibh volutpat pellentesque. Nunc porttitor quam eget blandit tempor. Fusce in est lacus. Aliquam commodo ultricies diam vel consequat. Aenean faucibus diam…
Recent Comments